| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.83▼ | 3.85▼ | 3.84▼ | 3.94▼ | 3.63▲ |
| MA10 | 3.86▼ | 3.83▼ | 3.82▼ | 3.95▼ | 3.90▼ |
| MA20 | 3.86▼ | 3.85▼ | 3.86▼ | 3.51▲ | 3.13▲ |
| MA50 | 3.83▼ | 3.94▼ | 3.99▼ | 3.95▼ | 2.40▲ |
| MA100 | 3.86▼ | 4.01▼ | 3.62▲ | 3.05▲ | 2.28▲ |
| MA200 | 4.00▼ | 3.57▲ | 3.56▲ | 2.60▲ | 4.14▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.008▲ | 0.002▲ | 0.059▲ | 0.011▲ |
| RSI | 43.078▼ | 44.942▼ | 45.055▼ | 52.523▲ | 57.263▲ |
| STOCH | 5.408▼ | 43.575 | 33.642 | 62.500 | 37.266 |
| WILL %R | -100.000▼ | -77.778▼ | -77.778▼ | -38.411 | -59.664 |
| CCI | -133.247▼ | -29.416 | -36.324 | 29.600 | 8.951 |
|
Thursday, November 08, 2018 02:56 AM
Heidelberg, Germany, November 8, 2018 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harnes...
|
|
Thursday, November 08, 2018 01:35 AM
Heidelberg, Germany, November 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that ...
|
|
Wednesday, November 07, 2018 11:53 AM
Start Time: 08:30 January 1, 0000 9:14 AM ET Affimed Therapeutics (NASDAQ:AFMD) Q3 2018 Earnings Conference Call November 07, 2018, 08:30 AM ET Executives Adi Hoess - CEO Florian Fischer - CFO ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/18 | 3.97 | 4.01 | 3.76 | 3.80 | 830,577 |
| 13/11/18 | 3.86 | 3.98 | 3.73 | 3.77 | 533,853 |
| 12/11/18 | 4.03 | 4.08 | 3.69 | 3.85 | 694,097 |
| 09/11/18 | 4.17 | 4.38 | 4.04 | 4.06 | 845,659 |
| 08/11/18 | 4.11 | 4.32 | 3.96 | 4.22 | 1,579,213 |
| 07/11/18 | 4.00 | 4.13 | 3.86 | 3.96 | 1,374,748 |
| 06/11/18 | 4.03 | 4.10 | 3.71 | 3.96 | 992,716 |
| 05/11/18 | 4.02 | 4.13 | 4.0016 | 4.02 | 1,042,392 |
| 02/11/18 | 3.70 | 4.25 | 3.70 | 4.10 | 1,848,561 |
| 01/11/18 | 3.25 | 4.14 | 3.25 | 3.71 | 2,779,559 |
|
|
||||
|
|
||||
|
|
||||
|
|